GLP-1 receptor agonists, particularly new generation agents such as semaglutide and tirzepatide, may significantly reduce the ...
China's path may not be a blueprint for others to copy, but the principles behind it offer valuable lessons for countries ...
The Ministry of Finance states in a press release that the criticism leveled by ELAS is based on “distortions, inaccuracies, ...